Evidence map›Paper›PMID 27724869›Full record

ArticleCardiovascular diabetology2016

Combined optical coherence tomography morphologic and fractional flow reserve hemodynamic assessment of non- culprit lesions to better predict adverse event outcomes in diabetes mellitus patients: COMBINE (OCT-FFR) prospective study. Rationale and design.

Mark W Kennedy, Enrico Fabris, Alexander J Ijsselmuiden, Holger Nef, Sebastian Reith, Javier Escaned, Fernando Alfonso, Niels van Royen, Wojtek Wojakowski, Adam Witkowski and 4 more

Registry-linked trialAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Cardiovascular diabetology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02989740 (Combined Optical Coherence Tomography Morphologic and Fractional Flow Reserve Hemodynamic Assessment of Non-Culprit Lesions to Better Predict Adverse Event Outcomes in Diabetes Mellitus Patients. COMBINE), which is not on this map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02989740 completednot on this map

Combined Optical Coherence Tomography Morphologic and Fractional Flow Reserve Hemodynamic Assessment of Non-Culprit Lesions to Better Predict Adverse Event Outcomes in Diabetes Mellitus Patients. COMBINE (OCT-FFR) Prospective Register

Typeobservational_patient_registrySponsorDiagram B.V.Ran2015 to 2021Enrolled550ConditionsDiabetes Mellitus, Coronary Artery Disease, Coronary AtherosclerosesArmsOptical Coherence Tomography
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2023
    Trial
  3. Trial
  4. Trial
  5. Vessel fractional flow reserve (vFFR) vs. optical coherence tomography in chronic coronary syndromes (VISION-FFR).Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  6. Impact of clinical risk characteristics on the prognostic value of high-risk plaques.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025
    Observational
  7. Article
  8. Article
  9. Vulnerable plaque features and adverse events in patients with diabetes mellitus: a post hoc analysis of the COMBINE OCT-FFR trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2024
    Article
  10. Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate Coronary Artery Lesions.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Contemporary Management of Stable Coronary Artery Disease.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mark W KennedyIsala Hartcentrum, Docter van Heesweg 2, Zwolle, The Netherlands.
Enrico FabrisIsala Hartcentrum, Docter van Heesweg 2, Zwolle, The Netherlands.
Alexander J IjsselmuidenAlbert Schweitzer Ziekenhuis, Dordrecht, The Netherlands.
Holger NefUniversity of Giessen, Giessen, Germany.
Sebastian ReithUniversity Hospital of the RWTH Aachen, Aachen, Germany.
Javier EscanedHospital Clinico San Carlos, Madrid, Spain.
Fernando AlfonsoHospital Universitario de La Princesa, Madrid, Spain.
Niels van RoyenVU University Medical Centre, Amsterdam, The Netherlands.
Wojtek WojakowskiMedical University of Silesia, Katowice, Poland.
Adam WitkowskiInstitute of Cardiology, Warsaw, Poland.
Ciro IndolfiAzienda Ospedaliera Universitaria Materdomini, Catanzaro, Italy.
Jan Paul OttervangerIsala Hartcentrum, Docter van Heesweg 2, Zwolle, The Netherlands.
Harry SuryapranataIsala Hartcentrum, Docter van Heesweg 2, Zwolle, The Netherlands.
Elvin KedhiIsala Hartcentrum, Docter van Heesweg 2, Zwolle, The Netherlands. e.kedhi@isala.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFractional flow reserve (FFR) is a widely used tool for the identification of ischaemia-generating stenoses and to guide decisions on coronary revascularisation. However, the safety of FFR-based decisions in high-risk subsets, such as patients with Diabetes Mellitus (DM) or vulnerable stenoses presenting thin-cap fibro-atheroma (TCFA), is unknown. This study will examine the impact of optical coherence tomography (OCT) plaque morphological assessment and the identification of TCFA, in combination with FFR to better predict clinical outcomes in DM patients.

methodsCOMBINE (OCT-FFR) is a prospective, multi-centre study investigating the natural history of DM patients with ≥1 angiographically intermediate target lesion in three subgroups of patients; patients with FFR negative lesions without TCFA (group A) and patients with FFR negative lesions with TCFA (group B) as detected by OCT and to compare these two groups with each other, as well as to a third group with FFR-positive, PCI-treated intermediate lesions (group C). The study hypothesis is that DM patients with TCFA (group B) have a worse outcome than those without TCFA (group A) and also when compared to those patients with lesions FFR ≤0.80 who underwent complete revascularisation. The primary endpoint is the incidence of target lesion major adverse cardiac events (MACE); a composite of cardiac death, myocardial infarction or rehospitalisation for unstable/progressive angina in group B vs. group A.

conclusionCOMBINE (OCT-FFR) is the first prospective study to examine whether the addition of OCT plaque morphological evaluation to FFR haemodynamic assessment of intermediate lesions in DM patients will better predict MACE and possibly lead to new revascularisation strategies. Trial Registration Netherlands Trial Register: NTR5376.

Indexed as

Cardiac CatheterizationFractional Flow Reserve, MyocardialHemodynamicsTomography, Optical CoherenceClinical ProtocolsCoronary AngiographyCoronary Artery DiseaseCoronary StenosisCoronary VesselsDiabetic AngiopathiesDisease ProgressionEuropeHumansPercutaneous Coronary InterventionPlaque, AtheroscleroticPredictive Value of TestsDiabetes mellitusFractional flow reserveMajor adverse cardiac event

Identifiers

PMID27724869
PMCPMC5057218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.